209 related articles for article (PubMed ID: 8756910)
1. Laser therapy for breast cancer: MR imaging and histopathologic correlation.
Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG
Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910
[TBL] [Abstract][Full Text] [Related]
2. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
[TBL] [Abstract][Full Text] [Related]
3. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Schaeffer U; Brix G; Essig M; Hoffmann U; Zuna I; Schönberg S; van Kaick G
Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
[TBL] [Abstract][Full Text] [Related]
4. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
[TBL] [Abstract][Full Text] [Related]
5. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Ruijs SH; Barentsz JO
Radiology; 1997 Jun; 203(3):645-52. PubMed ID: 9169683
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
7. Staging of symptomatic primary breast cancer with MR imaging.
Mumtaz H; Hall-Craggs MA; Davidson T; Walmsley K; Thurell W; Kissin MW; Taylor I
AJR Am J Roentgenol; 1997 Aug; 169(2):417-24. PubMed ID: 9242745
[TBL] [Abstract][Full Text] [Related]
8. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
9. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Semelka RC; Cumming MJ; Shoenut JP; Magro CM; Yaffe CS; Kroeker MA; Greenberg HM
Radiology; 1993 Mar; 186(3):799-802. PubMed ID: 8381551
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging.
Vogl TJ; Pegios W; Mack MG; Hünerbein M; Hintze R; Adler A; Lobbeck H; Hammerstingl R; Wust P; Schlag P; Felix R
AJR Am J Roentgenol; 1997 Jun; 168(6):1427-34. PubMed ID: 9168702
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
14. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.
Geirnaerdt MJ; Bloem JL; Eulderink F; Hogendoorn PC; Taminiau AH
Radiology; 1993 Mar; 186(3):813-7. PubMed ID: 8430192
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
Pierce WB; Harms SE; Flamig DP; Griffey RH; Evans WP; Hagans JE
Radiology; 1991 Dec; 181(3):757-63. PubMed ID: 1947093
[TBL] [Abstract][Full Text] [Related]
16. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
Guthrie JA; Ward J; Robinson PJ
Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
[TBL] [Abstract][Full Text] [Related]
17. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
[No Abstract] [Full Text] [Related]
18. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
Yasumoto M; Shibuya H; Takeda M; Korenaga T
AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
[TBL] [Abstract][Full Text] [Related]
20. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach.
Fischer U; Kopka L; Grabbe E
Radiology; 1999 Dec; 213(3):881-8. PubMed ID: 10580970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
